From: Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy
Author, year | Stage | Dose, BED10 | Local control | P value |
---|---|---|---|---|
Van der Voort van Zyp et al. 2009 [19] | T1, n = 35; T2, n = 24 | 180 Gy | 96 % at 2 years | n.s. p = 0.197 |
112. 5Â Gy | 78Â % at 2Â years | |||
Onimaru et al. 2008 [20] | T1, n = 25; T2, n = 16 | 80 Gy | 45 at 2 years | p = 0.0042 |
105.6Â Gy | 89Â % at 2Â years | |||
Guckenberger et al. 2009 [21] | T1, n = 13; T2, n = 19; T3N0, n = 9 | >100 Gy | 89 % at 3 years | p = 0.0001 |
<100Â Gy | 62Â % at 3Â years | |||
Bibault et al. 2012 [6] | T1, n = 31; T2, n = 20 | ≤150 Gy | 70 % at 2 years | p = 0.006 |
>150Â Gy | 100Â % at 2Â years | |||
Grills et al. 2012 [22] | T1, n = 318; T2, n = 67; T3, n = 10 | <105 Gy | 85 % at 2 years | p < 0.001 |
>105Â Gy | 96Â % at 2Â years | |||
Onishi et al. 2007 [23] | Stage I, n = 257 | >100 Gy | 84 % at 3 years | p <0.01 |
<100Â Gy | 37Â % at 3Â years |